Section 174 outlines the process for businesses to write off their Research and Experimentation (R&E) costs. According to tax laws, R&E expenses are considered to be costs related to Research and Development (R&D) in the “experimental or laboratory” context, which refers to efforts aimed at gaining knowledge to resolve doubts concerning the creation or enhancement of a product. The eligibility depends on the nature of the related activity, not the product of improvement being developed or the advancement that the product would jump start.
Under the current law, businesses are required to spread out deductions for these expenses over five years. However, the newly passed bill proposes to delay the onset of this requirement for domestic R&D costs until after December 31, 2025. This means that companies can continue to deduct expenses in the year they are incurred, at least for the next few years, providing immediate tax relief and encouraging continued investment in innovation. It’s important to note that the treatment of foreign research and experimental costs remains unchanged, with these expenses continuing to be amortized over a 15-year period.
The passing of this bill by the House represents a proactive approach to supporting business growth and innovation within the United States. By delaying the amortization of domestic R&D costs, easing business interest deduction limitations, and extending the 100% bonus depreciation, the legislation provides substantial tax relief and incentives for businesses to invest in their growth.
